2018
DOI: 10.1016/j.mefs.2018.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Serum visfatin as predictive marker of cardiometabolic risk in women with polycystic ovary syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 37 publications
1
0
0
Order By: Relevance
“…The results of the current study showed statistically significant elevations of obesity measures: BMI, WHR, FMI%, FFMI%, metabolic characteristics, and phenotype characteristic of PCOS compared to controls. The finding of our present study consistent with our previous studies [22][23][24][25][26].…”
Section: Discussionsupporting
confidence: 94%
“…The results of the current study showed statistically significant elevations of obesity measures: BMI, WHR, FMI%, FFMI%, metabolic characteristics, and phenotype characteristic of PCOS compared to controls. The finding of our present study consistent with our previous studies [22][23][24][25][26].…”
Section: Discussionsupporting
confidence: 94%